News

Following the firm’s $1.75bn acquisition of radiopharmaceuticals company Mariana Oncology and the $745m deal with Ratio ...
Pluri has announced the issuance of a patent by the US Patent and Trademark Office (USPTO) for its immune cell expansion ...
Belief BioMed (BBM) and Takeda China have announced China’s National Medical Products Administration's (NMPA) approval for ...
AstraZeneca’s Truqap (capivasertib) has been approved for use by the National Health Service (NHS) in England and Wales, ...
AI tools are faster at drafting clinical trial documents, but human writers remain indispensable for logical reasoning.
Biocon Biologics CEO and managing director Shreehas Tambe stated: “The US FDA approval of Jobevne (bevacizumab-nwgd) is a ...
The UK's MHRA has been redesignated as one of the WHO’s collaborating centres for the standardisation and evaluation of ...
APHA executive director Dr Georges C Benjamin has called for HHS secretary Robert F Kennedy, Jr (RFK Jr) to "resign or be ...